着床前遺伝子検査市場-世界の産業規模、シェア、動向、機会、予測、手順別、製品別、技術別、用途別、エンドユーザー別、地域別、競合別、2020年～2030年

着床前遺伝子検査の世界市場は、2024年には6億5,530万米ドルと評価され、2030年までには10億5,387万米ドルに達すると予測され、予測期間中のCAGRは8.20%で成長すると予測されています。

着床前遺伝子検査（PGT）は、生殖補助医療技術の中でも極めて重要な手順であり、主に体外受精（IVF）の際に、着床前に胚の遺伝子異常をスクリーニングするために使用されます。PGTには、染色体異数性を同定するPGT-Aと、一遺伝子異常を検出するPGT-Mの2種類があります。この検査は妊娠成功の可能性を高め、遺伝性疾患の伝播リスクを低減します。胚選択を改善し遺伝的リスクを軽減する能力を持つPGTは、特に遺伝的素因が既知のカップル間で、世界的に支持を集めています。意識の高まり、遺伝子診断の進歩、不妊治療サービスへのアクセスの増加が、この市場の拡大に拍車をかけています。

主要な市場促進要因

遺伝性疾患の発生率の上昇

主要な市場課題

倫理的・道徳的懸念

主要市場動向

着床前遺伝子検査（PGT）サービスを提供する不妊治療クリニックの増加

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 着床前遺伝子検査市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 手順別（着床前遺伝子スクリーニング、着床前遺伝子診断）
  • 製品別（試薬・消耗品、機器、ソフトウェア）
  • 技術別（次世代シーケンシング（NGS）、ポリメラーゼ連鎖反応（PCR）、蛍光in-situハイブリダイゼーション（FISH）、その他）
  • 用途別（染色体異常、X連鎖疾患、胚検査、異数性スクリーニング、HLAタイピング、その他）
  • エンドユーザー別（不妊治療センター、病院、診断センター、研究センター、学術研究室）
  • 地域別
  • 企業別（2024年）
• 市場マップ

第6章 北米の着床前遺伝子検査市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の着床前遺伝子検査市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋の着床前遺伝子検査市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の着床前遺伝子検査市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの着床前遺伝子検査市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 世界の着床前遺伝子検査市場：SWOT分析

第14章 競合情勢

• California Pacific Medical Center（CPMC）
• CombiMatrix Corp
• CooperSurgical, Inc.
• F. Hoffmann-La Roche Ltd.
• Genea Limited
• Genesis Genetics
• Good Start Genetics, Inc.
• IGENOMIX
• Illumina, Inc.
• Invitae Corporation
• Laboratory Corporation of America Holdings

第15章 戦略的提言

第16章 調査会社について・免責事項

The Global Preimplantation Genetic Testing Market was valued at USD 655.30 Million in 2024 and is projected to reach USD 1053.87 Million by 2030, growing at a CAGR of 8.20% during the forecast period. Preimplantation Genetic Testing (PGT) is a pivotal procedure within assisted reproductive technologies, primarily used during in vitro fertilization (IVF) to screen embryos for genetic abnormalities prior to implantation. The two key types of PGT include PGT-A, which identifies chromosomal aneuploidies, and PGT-M, which detects monogenic disorders. This testing enhances the chances of a successful pregnancy and reduces the risk of transmitting hereditary diseases. With its capacity to improve embryo selection and mitigate genetic risks, PGT is gaining traction globally, especially among couples with known genetic predispositions. Growing awareness, advancements in genetic diagnostics, and increased access to fertility services are fueling the expansion of this market.

Key Market Drivers

Rising Incidence of Genetic Disorders

A major factor propelling the preimplantation genetic testing market is the increasing prevalence of genetic disorders across global populations. These conditions affect a significant percentage of live births and early-life diagnoses, with approximately 5.3% of individuals worldwide being diagnosed with a genetic condition by age 25. This rising incidence has heightened the demand for early detection and intervention solutions, particularly among couples with hereditary risk factors. In regions such as the Middle East and North Africa, where consanguineous marriages are prevalent, the uptake of PGT is particularly strong due to elevated genetic risks. PGT offers a proactive approach to identifying embryos unaffected by hereditary diseases, improving reproductive outcomes and reducing long-term healthcare burdens. Its adoption is further supported by growing public and clinical awareness about genetic disorders and their impact on offspring health.

Key Market Challenges

Ethical And Moral Concern

Ethical and moral concerns surrounding the use of PGT remain a prominent challenge in the market. The technology's potential to enable selection based on non-medical traits-such as physical appearance or cognitive abilities-raises fears of societal discrimination and the possible emergence of "designer babies." These concerns fuel debates about fairness, equity, and human diversity. Additionally, the screening and possible discarding of embryos with genetic conditions is a contentious issue, particularly in societies where abortion and embryo manipulation are morally or religiously opposed. Such dilemmas pose regulatory hurdles and may limit acceptance and accessibility in certain regions, thereby restraining the market's growth despite its clinical potential.

Key Market Trends

Growing Number of Fertility Clinics Offering Preimplantation Genetic Testing (PGT) Services

An expanding network of fertility clinics offering PGT services is a notable trend boosting market accessibility and growth. As these clinics extend their reach into diverse geographies, patients in both urban and remote areas gain improved access to advanced reproductive and genetic services. The integration of PGT into fertility clinic offerings enhances the convenience of comprehensive care by combining IVF and genetic diagnostics under one roof. This growing availability fosters competitive service provision, technological innovation, and cost efficiencies. Furthermore, broader adoption of PGT in clinical settings is accelerating advancements in testing accuracy, turnaround times, and scope, including the ability to detect an expanded range of genetic abnormalities-thereby improving patient outcomes and expanding the market's potential.

Key Market Players

• California Pacific Medical Center (CPMC)
• CombiMatrix Corp
• CooperSurgical, Inc.
• F. Hoffmann-La Roche Ltd.
• Genea Limited
• Genesis Genetics
• Good Start Genetics, Inc.
• IGENOMIX
• Illumina, Inc.
• Invitae Corporation
• Laboratory Corporation of America Holdings

Report Scope:

In this report, the Global Preimplantation Genetic Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Preimplantation Genetic Testing Market, By Procedure:

• Preimplantation Genetic Screening
• Preimplantation Genetic Diagnosis

Preimplantation Genetic Testing Market, By Product:

• Reagents and Consumables
• Instruments
• Software

Preimplantation Genetic Testing Market, By Technology:

• Next Generation Sequencing (NGS)
• Polymerase Chain Reaction (PCR)
• Fluorescent In-Situ Hybridization (FISH)
• Others

Preimplantation Genetic Testing Market, By Application:

• Chromosomal Abnormalities
• X-linked Diseases
• Embryo Testing
• Aneuploidy Screening
• HLA Typing
• Other

Preimplantation Genetic Testing Market, By End User:

• Fertility Centers
• Hospitals
• Diagnostic Centers
• Research Centers and Academic Labs

Preimplantation Genetic Testing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Preimplantation Genetic Testing Market.

Available Customizations:

Global Preimplantation Genetic Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Preimplantation Genetic Testing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Procedure (Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis)
  • 5.2.2. By Product (Reagents and Consumables, Instruments, Software)
  • 5.2.3. By Technology (Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH), Others)
  • 5.2.4. By Application (Chromosomal Abnormalities, X-linked Diseases, Embryo Testing, Aneuploidy Screening, HLA Typing, Other)
  • 5.2.5. By End User (Fertility Centers, Hospitals, Diagnostic Centers, Research Centers and Academic Labs)
  • 5.2.6. By Region
  • 5.2.7. By Company (2024)
• 5.3. Market Map

6. North America Preimplantation Genetic Testing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Procedure
  • 6.2.2. By Product
  • 6.2.3. By Technology
  • 6.2.4. By Application
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Preimplantation Genetic Testing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Procedure
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Technology
      • 6.3.1.2.4. By Application
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Preimplantation Genetic Testing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Procedure
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Technology
      • 6.3.2.2.4. By Application
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Preimplantation Genetic Testing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Procedure
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Technology
      • 6.3.3.2.4. By Application
      • 6.3.3.2.5. By End User

7. Europe Preimplantation Genetic Testing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Procedure
  • 7.2.2. By Product
  • 7.2.3. By Technology
  • 7.2.4. By Application
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Preimplantation Genetic Testing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Procedure
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Technology
      • 7.3.1.2.4. By Application
      • 7.3.1.2.5. By End User
  • 7.3.2. United Kingdom Preimplantation Genetic Testing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Procedure
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Technology
      • 7.3.2.2.4. By Application
      • 7.3.2.2.5. By End User
  • 7.3.3. Italy Preimplantation Genetic Testing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Procedure
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Technology
      • 7.3.3.2.4. By Application
      • 7.3.3.2.5. By End User
  • 7.3.4. France Preimplantation Genetic Testing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Procedure
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Technology
      • 7.3.4.2.4. By Application
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Preimplantation Genetic Testing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Procedure
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Technology
      • 7.3.5.2.4. By Application
      • 7.3.5.2.5. By End User

8. Asia-Pacific Preimplantation Genetic Testing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Procedure
  • 8.2.2. By Product
  • 8.2.3. By Technology
  • 8.2.4. By Application
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Preimplantation Genetic Testing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Procedure
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Technology
      • 8.3.1.2.4. By Application
      • 8.3.1.2.5. By End User
  • 8.3.2. India Preimplantation Genetic Testing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Procedure
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Technology
      • 8.3.2.2.4. By Application
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Preimplantation Genetic Testing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Procedure
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Technology
      • 8.3.3.2.4. By Application
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Preimplantation Genetic Testing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Procedure
      • 8.3.4.2.2. By Product
      • 8.3.4.2.3. By Technology
      • 8.3.4.2.4. By Application
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Preimplantation Genetic Testing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Procedure
      • 8.3.5.2.2. By Product
      • 8.3.5.2.3. By Technology
      • 8.3.5.2.4. By Application
      • 8.3.5.2.5. By End User

9. South America Preimplantation Genetic Testing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Procedure
  • 9.2.2. By Product
  • 9.2.3. By Technology
  • 9.2.4. By Application
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Preimplantation Genetic Testing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Procedure
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Technology
      • 9.3.1.2.4. By Application
      • 9.3.1.2.5. By End User
  • 9.3.2. Argentina Preimplantation Genetic Testing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Procedure
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Technology
      • 9.3.2.2.4. By Application
      • 9.3.2.2.5. By End User
  • 9.3.3. Colombia Preimplantation Genetic Testing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Procedure
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Technology
      • 9.3.3.2.4. By Application
      • 9.3.3.2.5. By End User

10. Middle East and Africa Preimplantation Genetic Testing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Procedure
  • 10.2.2. By Product
  • 10.2.3. By Technology
  • 10.2.4. By Application
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Preimplantation Genetic Testing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Procedure
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Technology
      • 10.3.1.2.4. By Application
      • 10.3.1.2.5. By End User
  • 10.3.2. Saudi Arabia Preimplantation Genetic Testing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Procedure
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Technology
      • 10.3.2.2.4. By Application
      • 10.3.2.2.5. By End User
  • 10.3.3. UAE Preimplantation Genetic Testing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Procedure
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Technology
      • 10.3.3.2.4. By Application
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Preimplantation Genetic Testing Market: SWOT Analysis

14. Competitive Landscape

• 14.1. California Pacific Medical Center (CPMC)
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. CombiMatrix Corp
• 14.3. CooperSurgical, Inc.
• 14.4. F. Hoffmann-La Roche Ltd.
• 14.5. Genea Limited
• 14.6. Genesis Genetics
• 14.7. Good Start Genetics, Inc.
• 14.8. IGENOMIX
• 14.9. Illumina, Inc.
• 14.10.Invitae Corporation
• 14.11.Laboratory Corporation of America Holdings

15. Strategic Recommendations

16. About Us & Disclaimer